Our Chief Technology Officer, Rob Steendam, Chief Business Officer, Martin Bakker, and Business Development Manager, Vincent de Boer, will be attending the Dutch Life Science Conference in Leiden, where we’ll be showcasing our latest advancements in biodegradable long-acting injectable (LAI) technologies.
Our co-founder and CTO Rob Steendam will go into detail during his presentation on how InnoCore’s SynBiosys® polymer platform enables sustained release of peptides and biologics—without the common limitations of PLGA, such as aggregation, acylation, or high local pH.
We would love to discuss how our drug delivery technologies can support your development goals. Reach out to us directly through the contact form below, or contact us on: +31 50 575 3100